(Q35977830)

11 August 2017

Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3. (English)

1 reference

11 August 2017

Dixon AR

1

1 reference

11 August 2017

Price MR

2

1 reference

11 August 2017

Hand CW

3

1 reference

11 August 2017

Sibley PE

4

1 reference

11 August 2017

Selby C

5

1 reference

11 August 2017

Blamey RW

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

5

1 reference

11 August 2017

947-949

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.459

11 August 2017

0 references

cites work

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Value of CA 15:3 in the follow-up of breast cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Objective measurement of therapeutic response in breast cancer using tumour markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968729

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

11 July 2018

1 reference

12 December 2020

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization

1 reference

12 December 2020

Multiple epitopes on a human breast-carcinoma-associated antigen

1 reference

12 December 2020

CA15-3: its relationship to clinical stage and progression to metastatic disease in breast cancer

1 reference

12 December 2020

Assessment of four monoclonal antibodies as serum markers in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.459

1 reference

11 August 2017

1 reference

11 August 2017

1 reference